The contact activation system as a potential therapeutic target in patients with COVID‐19-Reference-Cited by-同舟云学术

The contact activation system as a potential therapeutic target in patients with COVID‐19

Published:2020-05 Issue:4 Volume:4 Page:500-505
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Shatzel Joseph J.¹²,DeLoughery Emma P.³,Lorentz Christina U.²⁴,Tucker Erik I.²⁴,Aslan Joseph E.⁵^ORCID,Hinds Monica T.²,Gailani David⁶,Weitz Jeffrey I.⁷,McCarty Owen J. T.¹²,Gruber Andras¹²⁴

Affiliation:

1. Division of Hematology and Oncology Oregon Health & Science University Portland OR USA

2. Department of Biomedical Engineering Oregon Health & Science University Portland OR USA

3. Mayo Clinic Alix School of Medicine Mayo Clinic Rochester MN USA

4. Aronora, Inc. Portland OR USA

5. Knight Cardiovascular Institute Oregon Health & Science University Portland OR USA

6. Vanderbilt University Medical Center Nashville TN USA

7. The Thrombosis and Atherosclerosis Research Institute and McMaster University Hamilton ON Canada

Funder

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

National Institute of Neurological Disorders and Stroke

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12349

Reference27 articles.

1. XuX HanM LiT SunW WangD FuB ZhouY ZhengX YangY LiX ZhangX PanA WeiH.Effective treatment of severe COVID‐19 patients with tocilizumab. ChinaXiv:202003000262020; in press.

2. Genentech: Press Releases| Monday March 23 2020.

3. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

4. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

5. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evolutionary history of F12 gene: Emergence, loss, and vulnerability with the environment as a driver;BioEssays;2023-09-26

2. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence;International Journal of Molecular Sciences;2023-05-18

3. Venous thromboembolism in viral diseases: A comprehensive literature review;Health Science Reports;2023-02

4. Physiological and pathological role of factor XII;Russian journal of hematology and transfusiology;2022-12-27

5. Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study;Thrombosis Journal;2022-08-29